BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543363

PREVEST

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Prevest Denpro Limited Share Price Update

As of the latest trading session, Prevest Denpro Limited share price is currently at ₹ 565, which is up by ₹ 5.00 from its previous closing. Today, the stock has fluctuated between ₹ 551.15 and ₹ 568.50. Over the past year, Prevest Denpro Limited has achieved a return of -1.05 %. In the last month alone, the return has been -1.26 %. Read More...

Investment Returns

Over 1 Month -1.26% Over 3 Months 15.93% Over 6 Months 33.03% Over 1 Year -1.05%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Prevest Denpro Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    678.20

  • P/E Ratio (TTM)

    35.36

  • Beta

    0.71

  • Book Value / share

    87.98

  • Return on equity

    18.74%

  • EPS (TTM)

    15.98

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    4.63

info icon alternate text

Prevest Denpro Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 15.72
Operating Expense 10.68
Net Profit 4.63
Net Profit Margin (%) 29.45
Earnings Per Share (EPS) 3.86
EBITDA 6.70
Effective Tax Rate (%) 25.44
Particulars MAR 2025 (Values in Cr)
Revenue 18.54
Operating Expense 12.39
Net Profit 5.25
Net Profit Margin (%) 28.31
Earnings Per Share (EPS) 4.37
EBITDA 7.70
Effective Tax Rate (%) 27.52
Particulars DEC 2024 (Values in Cr)
Revenue 14.93
Operating Expense 10.27
Net Profit 4.46
Net Profit Margin (%) 29.87
Earnings Per Share (EPS) 3.72
EBITDA 6.24
Effective Tax Rate (%) 22.39
Particulars SEP 2024 (Values in Cr)
Revenue 16.26
Operating Expense 10.91
Net Profit 4.84
Net Profit Margin (%) 29.76
Earnings Per Share (EPS) 4.03
EBITDA 6.88
Effective Tax Rate (%) 24.49
Particulars JUN 2024 (Values in Cr)
Revenue 13.34
Operating Expense 9.33
Net Profit 3.65
Net Profit Margin (%) 27.36
Earnings Per Share (EPS) 3.04
EBITDA 5.35
Effective Tax Rate (%) 25.05
Particulars MAR 2025 (Values in Cr)
Revenue 63.07
Operating Expense 42.90
Net Profit 18.20
Net Profit Margin (%) 28.85
Earnings Per Share (EPS) 15.16
EBITDA 26.16
Effective Tax Rate (%) 25.01
Particulars MAR 2024 (Values in Cr)
Revenue 56.44
Operating Expense 37.89
Net Profit 16.12
Net Profit Margin (%) 28.56
Earnings Per Share (EPS) 13.44
EBITDA 22.69
Effective Tax Rate (%) 24.70
Particulars MAR 2023 (Values in Cr)
Revenue 49.85
Operating Expense 30.93
Net Profit 15.71
Net Profit Margin (%) 31.51
Earnings Per Share (EPS) 13.09
EBITDA 21.64
Effective Tax Rate (%) 25.04
Particulars MAR 2022 (Values in Cr)
Revenue 38.11
Operating Expense 23.68
Net Profit 11.57
Net Profit Margin (%) 30.35
Earnings Per Share (EPS) 9.64
EBITDA 16.67
Effective Tax Rate (%) 27.91
Particulars MAR 2021 (Values in Cr)
Revenue 28.48
Operating Expense 20.18
Net Profit 7.21
Net Profit Margin (%) 25.31
Earnings Per Share (EPS) 8.16
EBITDA 10.00
Effective Tax Rate (%) 22.80
Particulars MAR 2025 (Values in Cr)
Book Value / Share 87.95
ROE % 18.70
ROCE % 25.24
Total Debt to Total Equity 0.00
EBITDA Margin 40.66
Particulars MAR 2024 (Values in Cr)
Book Value / Share 73.83
ROE % 18.21
ROCE % 24.43
Total Debt to Total Equity 0.00
EBITDA Margin 39.18
Particulars MAR 2025 (Values in Cr)
Book Value / Share 87.98
ROE % 18.74
ROCE % 25.25
Total Debt to Total Equity 0.00
EBITDA Margin 40.65
Particulars MAR 2024 (Values in Cr)
Book Value / Share 73.82
ROE % 19.98
ROCE % 26.79
Total Debt to Total Equity 0.00
EBITDA Margin 39.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 60.65
ROE % 24.19
ROCE % 32.26
Total Debt to Total Equity 0.01
EBITDA Margin 43.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.56
ROE % 29.08
ROCE % 39.64
Total Debt to Total Equity 0.03
EBITDA Margin 42.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 789.33
ROE % 38.14
ROCE % 46.79
Total Debt to Total Equity 0.08
EBITDA Margin 34.68
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 60.89
Total Assets 112.52
Total Liabilities 112.52
Total Equity 105.57
Share Outstanding 12003000
Price to Book Ratio 4.87
Return on Assets (%) 16.13
Return on Capital (%) 17.2
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 48.61
Total Assets 94.81
Total Liabilities 94.81
Total Equity 88.61
Share Outstanding 12003000
Price to Book Ratio 4.78
Return on Assets (%) 17.01
Return on Capital (%) 18.21
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 60.46
Total Assets 112.67
Total Liabilities 112.67
Total Equity 105.60
Share Outstanding 12003000
Price to Book Ratio 4.87
Return on Assets (%) 16.15
Return on Capital (%) 17.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 48.42
Total Assets 94.81
Total Liabilities 94.81
Total Equity 88.60
Share Outstanding 12003000
Price to Book Ratio 4.78
Return on Assets (%) 17.00
Return on Capital (%) 18.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 39.00
Total Assets 78.60
Total Liabilities 78.60
Total Equity 72.79
Share Outstanding 12003000
Price to Book Ratio 4.59
Return on Assets (%) 19.98
Return on Capital (%) 21.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 42.31
Total Assets 64.14
Total Liabilities 64.14
Total Equity 57.08
Share Outstanding 12003000
Price to Book Ratio 7.59
Return on Assets (%) 18.03
Return on Capital (%) 19.79
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 16.42
Total Assets 30.67
Total Liabilities 30.67
Total Equity 22.49
Share Outstanding 285000
Price to Book Ratio 0.00
Return on Assets (%) 23.49
Return on Capital (%) 30.17
Particulars MAR 2025 (Values in Cr)
Net Income 24.24
Cash from Operations 20.86
Cash from Investing -1.32
Cash from Financing -1.20
Net change in Cash 12.28
Free Cash Flow 22.83
Particulars MAR 2024 (Values in Cr)
Net Income 21.43
Cash from Operations 16.25
Cash from Investing -1.70
Cash from Financing -0.31
Net change in Cash 9.60
Free Cash Flow 19.98
Particulars MAR 2025 (Values in Cr)
Net Income 24.27
Cash from Operations 21.00
Cash from Investing -1.74
Cash from Financing -1.20
Net change in Cash 12.03
Free Cash Flow 22.95
Particulars MAR 2024 (Values in Cr)
Net Income 21.41
Cash from Operations 16.11
Cash from Investing -1.75
Cash from Financing -0.31
Net change in Cash 9.42
Free Cash Flow 19.84
Particulars MAR 2023 (Values in Cr)
Net Income 20.95
Cash from Operations 15.59
Cash from Investing -12.37
Cash from Financing -1.36
Net change in Cash -3.31
Free Cash Flow 29.11
Particulars MAR 2022 (Values in Cr)
Net Income 16.05
Cash from Operations 11.39
Cash from Investing -3.86
Cash from Financing 22.81
Net change in Cash 25.91
Free Cash Flow 16.28
Particulars MAR 2021 (Values in Cr)
Net Income 9.33
Cash from Operations 10.65
Cash from Investing -1.92
Cash from Financing -0.56
Net change in Cash 6.26
Free Cash Flow 12.88
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7606.75 69.51 13.33 109373.39 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 67.18 27.31 4.16 125.91 51.01 / 98.70
SHREE PACETRONIX LTD. 164.06 56.57 4.28 59.05 61.11 / 192.00
TRANSGENE BIOTEK LTD. 3.88 0.00 2.93 29.40 3.22 / 9.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7606.75 80.93 12.52 109373.39 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 38.00 0.00 -15.01 28.39 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6343.55 31.48 6.38 6939.84 4777.15 / 6525.00

Prevest Denpro Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
565.00 0.89 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 563.50
  • 26 Days 552.60
  • 10 Days 559.00
  • 50 Days 541.30
  • 12 Days 557.80
  • 100 Days 527.70
  • 20 Days 554.80
  • 200 Days 520.70
565.37 PIVOT

First Support

550.73

First Resistance

574.63

Second Support

541.47

Second Resistance

589.27

Third Support

526.83

Third Resistance

598.53

RSI

54.91

ADX

7.60

MACD

5.24

Williams % R

-39.84

Commodity Channel Index (CCI)

73.47

Date

2025-08-29

Week

6560.00

Same Day

2200.00

Month

4700.00

1 Year

0.71

3 Year

0.87

Over 1 Month

-1.26%

down

Over 1 Year

-1.05%

down

Over 3 Months

15.93%

down

Over 3 Years

11.16%

down

Over 6 Months

33.03%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Prevest Denpro Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Prevest Denpro Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Sep 2025 1.0 Final 03 Sep 2025 Equity shares
30 Aug 2024 1.0 Final 30 Aug 2024 Equity shares
23 Aug 2023 1.0 Final 23 Aug 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Prevest Denpro Limited Share Price

Prevest Denpro Limited is one of the world's leading dental materials manufacturer, which was incorporated on May 05, 1999, with the Registrar of Companies, Jammu & Kashmir. The Company is primarily involved in the manufacturing of Dental Preparations.

The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The product offerings addresses majority of dentists' clinical needs for consumable dental materials. The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa.

The manufacturing facility is located at Kartholi, Samba (Jammu & Kashmir), comprising of over 27,000 sq. ft. area and has an installed capacity of 200 MT p.a. for manufacturing of dental materials. Further, as per diversification plans, the Company is currently expanding manufacturing unit by setting up another manufacturing facility in over 16,000 sq. ft. area adjacent to existing unit for manufacturing new line of products including, hygiene products (sanitizers and disinfectants), oral hygiene products (mouth washes and mouth rinses), oral care products (medicated ointments, gels and creams for dental treatment) and biomaterials (i.e. bone augmentation materials).

The Company sell products through a network of 53 dealers spread over 16 states and 2 Union Territories in India and through 91 overseas agents spread over 75 countries. The Company primarily follow a business-to-business model for all dental products. Further, Company have started selling certain products to direct consumers on digital market platforms such as Amazon and through its own web-platform i.e. prevestdirect.com. It recently purchased an office in Gurugram, Haryana, which will be used for marketing of products to customers in the North Indian region. The Company is diversifying into manufacturing of disinfectants, oral hygiene products, oral healthcare and bio-material products as well.

The Company work with different dealers and overseas agents depending on their geographical reach, market knowledge, product and customer awareness as well as understanding of dental industry. The distribution network is aided by capable in-house sales and marketing team which liaise with dealers and overseas agents on a regular basis for customer inputs, market demands as well as positioning of products vis-à-vis products of competitors. The Company also has a research & development department that is responsible for development of high-quality innovative dental materials.

In the year 2000, the Company's first manufacturing unit was established at Digiana, in Jammu & Kashmir.
In 2011, the second manufacturing unit was established at Samba, in J&K.
In 2016, the Company won Sushruta Award for Best Dental Manufacture by the Indian Dental Associations'.
In 2016, the Company received Certificate for Best Enterprise' in the field of manufacture of dental materials, India by the Socrates Committee, Oxford, UK.
In 2017, the Company shifted manufacturing operations from first manufacturing unit to second manufacturing unit.
In 2017, the Company won 'Northern Region Export Excellence Award' - Gold Trophy for outstanding export performance in the category of top exporter J&K - SME by FIEO (2017).

Promoters of the Company have collaboration with 5 reputed dental universities & institutions like, Terna Dental College & Hospital, Mumbai; A.B. Shetty Memorial Institute of Dental Sciences, Mangalore, Karnataka ; Army College of Dental Sciences, Secunderabad, Telangana; R.S.M.N.N. Sattha College of Pharmacy, Ahmednagar, Maharashtra and J.M.F.'s A.C.P.M. Dental College, Dhule, Maharashtra for exchange of technical knowledge and conducting training & research on dental materials. The Company also entered into license agreement with Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum for obtaining the know-how and rights to manufacture bioactive bone cement based on calcium sulfate and calcium phospho-silicate composite (HA-BG) Granules. The Company also have an advisory board of dental professionals which provides an overall industry and business guidance to Board of Directors.

The Company largely face competition from international companies which includes Danaher Corporation, Dentsply Sirona, Voco, Institute Straumann AG, Osstem Implant Co. Ltd., Zimmer Biomet, Medicept UK Ltd., Mani Inc. KAVO G C, Ivoclar-Vivadent, Nobel Biocare, 3M, G C Dental and Shofu Dental. Further, some of the Indian companies which are considered to be as a part of the competitors include 3M India Ltd., Prime Dental Products Private Limited, OriKam Healthcare India Private Limited, Dental Avenue (I) Private Limited, Vishal Dentocare Pvt. Limited and D Tech Orthodontics Pvt Ltd. Further, the main raw materials which are required to manufacture dental products includes zinc oxide, pumice powder, aluminium chloride, camphor, glycerine, paraffin, zirconium oxide, eugenol, diatomaceous earth, waxes etc. which are procured by the Company from domestic vendors. Further, certain raw materials such as Aerosil, Bisphenol A Bis Propyl Ether, Ethoxylated Bisphenol A Dimethacrylate, Triethylene Glycol Dimethacrylate, Urethane Dimethacrylate, Glass Powders, Sodium Alginate etc. are imported from international vendors located in Germany, USA, Korea and China by the Company.

In September 2021, the Company floated an IPO of 31,68,000 Equity Shares. In 2023, Company launched Oradox brand in 2023. It incorporated DenVisio Biomed Limited in 2023. It incorporated Axiodent Inc. as wholly owned subsidiary in the United States in February, 2025.

Parent organization Indian Private
NSE symbol [-]
Founded 1999
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Prevest Denpro Ltd?

Answer Field

Prevest Denpro Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 565.00 as on Aug 29 2025 03:17 PM.

What is the Market Cap of Prevest Denpro Ltd Share?

Answer Field

The market cap of Prevest Denpro Ltd for NSE ₹ 0.00 & for BSE ₹ 678.20 as on Aug 29 2025 03:17 PM.

What is the 52 Week High and Low of Prevest Denpro Ltd?

Answer Field

The 52 Week High and Low of Prevest Denpro Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 686.00 and ₹ 393.60.

What is 1 year return for Prevest Denpro Ltd?

Answer Field

The 1 year returns on the stock has been -1.05%.

What is the P/E Ratio of Prevest Denpro Ltd Share?

Answer Field

As on Aug 29 2025 03:17 PM the price-to-earnings (PE) ratio for Prevest Denpro Ltd share is 35.36.

What is the PB ratio of Prevest Denpro Ltd Share?

Answer Field

As on Aug 29 2025 03:17 PM, the price-to-book (PB) ratio for Prevest Denpro Ltd share is 87.98.

How to Buy Prevest Denpro Ltd Share?

Answer Field

You can trade in Prevest Denpro Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Prevest Denpro Ltd Share on Bajaj Broking App?

Answer Field

To buy Prevest Denpro Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Prevest Denpro Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91